PARP inhibitors
Poly (ADP-ribose) polymerase (PARP) inhibitors represent a class of therapeutic agents employed in the management of cancer, neurodegenerative disorders, and cardiovascular diseases.
Browse protocols, FAQs, guidelines, and technical articles tagged “treat tumors”, newest first. For research use only.
Poly (ADP-ribose) polymerase (PARP) inhibitors represent a class of therapeutic agents employed in the management of cancer, neurodegenerative disorders, and cardiovascular diseases.
Pim kinases are a family of serine/threonine kinases that play critical roles in regulating cell cycle progression and programmed cell death (apoptosis). Two major isoforms have been identified—Pim-1 and Pim-2—both of which are expressed in lymphoid cells and are essential for ...
paclitaxel was first identified in 1971 as a potent anticancer compound. Originally isolated from the bark of the Pacific yew tree (Taxus brevifolia Nutt.), it has since been produced through synthetic and semi-synthetic approaches, ensuring broader accessibility for clinical and research use.
The Janus kinase (JAK) signal transduction and transcriptional activator (STAT) pathway plays a key role in the signaling of a large number of cytokines and growth factors. These cytokines and growth factors are responsible for a variety of cellular functions, including proliferation, growth, ...
Papain is an enzyme with a protein hydrolytic function and cysteine protease activity. The enzyme belongs to a superfamily that consists of a single polypeptide chain containing three disulfide bonds and a sulfhydryl group essential for enzymatic activity and is derived from the green papaya, ...
Topics that share resources with this page.